Gary A. Palmer

4.7k total citations
70 papers, 2.7k citations indexed

About

Gary A. Palmer is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gary A. Palmer has authored 70 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cancer Research, 32 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gary A. Palmer's work include Cancer Genomics and Diagnostics (32 papers), Lung Cancer Treatments and Mutations (21 papers) and Colorectal Cancer Treatments and Studies (7 papers). Gary A. Palmer is often cited by papers focused on Cancer Genomics and Diagnostics (32 papers), Lung Cancer Treatments and Mutations (21 papers) and Colorectal Cancer Treatments and Studies (7 papers). Gary A. Palmer collaborates with scholars based in United States, France and Israel. Gary A. Palmer's co-authors include Vincent A. Miller, Philip J. Stephens, Roman Yelensky, Doron Lipson, Jeffrey S. Ross, Siraj M. Ali, Kai Wang, Geoff Otto, Deborah Morosini and Christine E. Sheehan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Gary A. Palmer

67 papers receiving 2.7k citations

Peers

Countries citing papers authored by Gary A. Palmer

Since Specialization

Citations

This map shows the geographic impact of Gary A. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Palmer more than expected).

Fields of papers citing papers by Gary A. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Palmer. The network helps show where Gary A. Palmer may publish in the future.

Co-authorship network of co-authors of Gary A. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Palmer. A scholar is included among the top collaborators of Gary A. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Palmer. Gary A. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data 2020 ·Clinical Breast Cancer ·(unknown), Caroline G. Epstein, Alexandria M. Bobe, Joshua S. K. Bell, Martin C. Stumpe, (unknown), Ameen A. Salahudeen, (unknown), (unknown), (unknown), (unknown), Catherine Igartua, Robert Huether, Ashraf Hafez, Nike Beaubier, Michael D. Axelson, Mark D. Pegram, Sarah Sammons, Joyce O’Shaughnessy, Gary A. Palmer	10
2	Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations 2015 ·Breast Cancer Research and Treatment ·Jeffrey S. Ross, Siraj M. Ali, Kai Wang, Depinder Khaira, Norma Alonzo Palma, Juliann Chmielecki, Gary A. Palmer, Deborah Morosini, Julia A. Elvin, Sandra V. Fernandez, Vincent A. Miller, Philip J. Stephens, Massimo Cristofanilli	61
3	Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer 2014 ·Molecular Cancer Therapeutics ·Funda Meric‐Bernstam, Garrett M. Frampton, Jaime Ferrer-Lozano, Roman Yelensky, José Alejandro Pérez Fidalgo, Ying Wang, Gary A. Palmer, Jeffrey S. Ross, Vincent A. Miller, Xiaoping Su, Pîlar Eroles, Juan Antonio Barrera, Octavio Burgués, Aňa Lluch, Xiaofeng Zheng, Ayşegül Şahin, Philip J. Stephens, Gordon B. Mills, Maureen Cronin, Ana M. González-Angulo	68
4	Response of an ERBB2-Mutated Inflammatory Breast Carcinoma to Human Epidermal Growth Factor Receptor 2–Targeted Therapy 2014 ·Journal of Clinical Oncology ·Siraj M. Ali, R. Katherine Alpaugh, Sean R. Downing, Philip J. Stephens, Jian Yu, Hong Wu, Jamie Buell, Vincent A. Miller, Doron Lipson, Gary A. Palmer, Jeffrey S. Ross, Massimo Cristofanilli	40
5	Oncogenic Alterations in ERBB2/HER2 Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin 2014 ·The Oncologist ·Juliann Chmielecki, Jeffrey S. Ross, Kai Wang, Garrett M. Frampton, Gary A. Palmer, Siraj M. Ali, Norma Alonzo Palma, Deborah Morosini, Vincent A. Miller, Roman Yelensky, Doron Lipson, Philip J. Stephens	75
6	Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary 2014 ·Case Reports in Oncology ·Norma Alonzo Palma, Siraj M. Ali, (unknown), (unknown), Kai Wang, Salil Soman, Gary A. Palmer, Deborah Morosini, Jeffrey S. Ross, Doron Lipson, Phil Stephens, Mayur M. Patel, Vincent A. Miller, (unknown)	23
7	Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein 2014 ·Journal of Hematology & Oncology ·Vivek Subbiah, Shannon N. Westin, Kai Wang, Dejka M. Araujo, Wei‐Lien Wang, Vincent A. Miller, Jeffrey S. Ross, P. J. Stephens, Gary A. Palmer, Siraj M. Ali	53
8	RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma 2014 ·The Journal of Clinical Endocrinology & Metabolism ·Elizabeth G. Grubbs, Patrick Kwok‐Shing Ng, (unknown), Naifa L. Busaidy, Ken Chen, Jeffrey E. Lee, Xinyan Lu, Hengyu Lu, Funda Meric‐Bernstam, Gordon B. Mills, Gary A. Palmer, Nancy D. Perrier, Kenneth L. Scott, Kenna Shaw, Steven G. Waguespack, Michelle D. Williams, Roman Yelensky, Gilbert J. Cote	67
9	Comprehensive Genomic Profiling of Relapsed and Metastatic Adenoid Cystic Carcinomas by Next-generation Sequencing Reveals Potential New Routes to Targeted Therapies 2014 ·The American Journal of Surgical Pathology ·Jeffrey S. Ross, Kai Wang, (unknown), Christine E. Sheehan, Timothy A. Jennings, Rami N. Al‐Rohil, Geoff Otto, (unknown), Gary A. Palmer, Sean R. Downing, Roman Yelensky, Doron Lipson, Sohail Balasubramanian, Lázaro Ibrahim Romero García, (unknown), Siraj M. Ali, Vincent A. Miller, Philip J. Stephens	50
10	Vemurafenib Response in 2 Patients With Posttransplant Refractory BRAF V600E–Mutated Multiple Myeloma 2014 ·Clinical Lymphoma Myeloma & Leukemia ·Jeff P. Sharman, Juliann Chmielecki, Deborah Morosini, Gary A. Palmer, Jeff Ross, P. J. Stephens, (unknown), V.A. Miller, Sonia Ali	41
11	Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies 2013 ·Gynecologic Oncology ·Jeffrey S. Ross, Siraj M. Ali, (unknown), Gary A. Palmer, Roman Yelensky, Doron Lipson, V.A. Miller, Deborah A. Zajchowski, Laura K. Shawver, Philip J. Stephens	72
12	Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy 2013 ·Modern Pathology ·Jeffrey S. Ross, Kai Wang, Rami N. Al‐Rohil, Tipu Nazeer, Christine E. Sheehan, Geoff Otto, Jie He, Gary A. Palmer, Roman Yelensky, Doron Lipson, Siraj M. Ali, Sohail Balasubramanian, John A. Curran, (unknown), (unknown), Sean R. Downing, Matthew Hawryluk, Vincent A. Miller, Philip J. Stephens	119
13	Antitumor Response of an ERBB2 Amplified Inflammatory Breast Carcinoma With EGFR Mutation to the EGFR-TKI Erlotinib 2013 ·Clinical Breast Cancer ·Siraj M. Ali, (unknown), Jamie Buell, Philip J. Stephens, Jian Q. Yu, Hong Wu, (unknown), Vincent A. Miller, Doron Lipson, Gary A. Palmer, Jeffrey S. Ross, Massimo Cristofanilli	17
14	Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors 2013 ·Genome Medicine ·Matthias Lechner, Garrett M. Frampton, Tim R. Fenton, Andrew Feber, Gary A. Palmer, Amrita Jay, Nischalan Pillay, Martin Förster, Maureen Cronin, Doron Lipson, Vincent A. Miller, Timothy Brennan, Stephen Henderson, Francis Vaz, Paul O’Flynn, Nicholas Kalavrezos, Roman Yelensky, Stephan Beck, Philip J. Stephens, Chris Boshoff	169
15	Relapsed Classic E-Cadherin ( CDH1 )–Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 ( ERBB2 ) Gene Mutations 2013 ·Clinical Cancer Research ·Jeffrey S. Ross, Kai Wang, Christine E. Sheehan, Ann Boguniewicz, Geoff Otto, Sean R. Downing, James Sun, Jie He, John A. Curran, Siraj M. Ali, Roman Yelensky, Doron Lipson, Gary A. Palmer, Vincent A. Miller, Philip J. Stephens	96
16	Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer 2012 ·Journal of Thoracic Oncology ·Nir Peled, Gary A. Palmer, Fred R. Hirsch, Murry W. Wynes, Maya Ilouze, Marileila Varella‐Garcia, Lior Soussan‐Gutman, Geoff Otto, Philip J. Stephens, Jeffrey S. Ross, Maureen Cronin, Doron Lipson, Vincent A. Miller	102
17	Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study 2004 ·The American Journal of Cardiology ·Terje R. Pedersen, Ole Færgeman, John J.P. Kastelein, Anders Olsson, Matti J. Tikkanen, Ingar Holme, Mogens Lytken Larsen, Fredrik Bendiksen, Christina Lindahl, Gary A. Palmer	44
18	Site-specific antibodies against hydrophilic domains of subunit III of bovine heart cytochrome c oxidase affect enzyme function 2003 ·Archives of Biochemistry and Biophysics ·A. Jeannine Lincoln, (unknown), Gary A. Palmer, Lawrence J. Prochaska	10
19	An examination of atorvastatin safety when used in c combination with verapamil: Evidence from 44 completed clinical trials 2003 ·Journal of the American College of Cardiology ·William J. Sasiela, Michael Szarek, Halit Silbershatz, Gary A. Palmer	1
20	The Treatment of Choroidal Neovascular Membranes by Alpha Interferon 1994 ·Ophthalmology ·Clement K. Chan, Sanford Kempin, (unknown), Gary A. Palmer	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact